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Abstract: 36 
Objective: Examine the prospective relationship between Physical activity (PA) and incident 37 
depression and explore potential moderators. 38 
Methods: Prospective cohort studies evaluating incident depression were searched from 39 
database inception to October 18, 2017 on PubMed, PsycINFO, EMBASE and Sportsdiscuss. 40 
Demographic and clinical data, PA and depression assessment, and Odds Ratios (ORs), 41 
Relative Risks (RRs) and Hazard Ratios (HRs) and 95% confidence interval data were 42 
extracted. Random effects meta-analyses were conducted and the potential sources of 43 
heterogeneity were explored. Methodological quality was assessed using the Newcastle Ottawa 44 
Scale (NOS).    45 
Results: A total of 49 unique prospective studies (n=266,939, median of males/females across 46 
studies=47%/53%) were followed up for 1,837,794 person-years. People with high PA (versus 47 
low PA) were at reduced odds of developing depression ((adjusted)AOR=0.83, 95%CI=0.79 to 48 
0.88, p<0.001, I2=0.00). Furthermore, PA had a protective effect upon the emergence of 49 
depression in youth (AOR=0.90, 95%CI=0.83 to 0.98), in adults (AOR=0.78, 95%CI=0.70 to 50 
0.87), and the elderly (AOR=0.79, 95%CI=0.72 to 0.86). Protective effects were found across 51 
geographical regions: Asia (AOR=0.76, 95%CI=0.68 to 0.85), Europe (AOR=0.83, 95%CI=0.73 52 
to 0.95), North-America (AOR=0.84, 95%CI=0.79 to 0.93) and Oceania (AOR=0.65, 53 
95%CI=0.48 to 0.89), and for increased incidence of positive screen for depressive symptoms 54 
(AOR=0.84, 95%CI=0.79 to 0.89) or MDD diagnosis (AOR=0.86, 95%CI=0.75 to 0.98). No 55 
moderators were identified. Results were consistent for unadjusted ORs and for adjusted and 56 
unadjusted RR/HR. Overall study quality was moderate to high (NOS=6.3). Although significant 57 
publication bias was found, adjusting for this did not change the magnitude of the associations. 58 
Conclusions: Available evidence supports the notion that PA can confer protection against the 59 
emergence of depression regardless of age and geographical region.  60 
 61 
Key Words: exercise, physical activity, depression, cohort, prevention, incidence 62 
 63 
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Introduction 66 
 Depressive disorders are the second leading cause of global burden and account for 67 
44,224.4 thousands of years lived with disability (YLDs) (1). They are associated with 68 
heightened medical comorbidity (2), increased healthcare costs (3) and premature mortality (4). 69 
Given the breadth of depressive disorders and the individual and societal burden, strategies that 70 
may reduce the onset of depression are urgently required (5).  71 
 One potentially modifiable risk factor for the onset of depression is low physical activity 72 
(PA) (6). People with major depressive disorder (MDD) are known to have a 50% odds of not 73 
meeting the recommended PA levels (e.g., performing > 150 minutes of moderate intensity 74 
physical activity each week), compared with people without the disorder (7). Moreover, 75 
structured PA is known to reduce depressive symptoms in those with depression (8). Previous 76 
systematic reviews suggest that PA is a protective factor for depression onset (9, 10), with even 77 
small amounts of PA (e.g., walking <150 minutes per week) decreasing the incidence of future 78 
depressive episodes (9). The studies, however, have not conducted meta-analyses to quantify 79 
the magnitude of the protective role of PA (9). Moreover, the role of moderators such as gender, 80 
and age, which may influence the relationship between PA and depression, have not been 81 
explored.   82 
 Given these gaps, our aims were to: (a) systematically review and meta-analyze 83 
prospective cohort studies examining the role of physical activity to reduce symptoms of 84 
depression; (b) explore potential moderators including age at baseline, geographical location, 85 
gender, length of follow-up, study quality, number of covariates used in the model, sample size 86 
of the study and total person-years; and, (c) evaluate the quality of the studies. 87 
 88 
Methods  89 
 This review adhered to the Meta-analysis Of Observational Studies in Epidemiology 90 
(MOOSE) (11) guidelines and Preferred Reporting Items for Systematic Reviews and Meta-91 
analyses (PRISMA) (12) statement, following an apriori defined yet unpublished protocol 92 
(available upon request). 93 
 94 
Search procedure 95 
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 Two researchers (FS, ES) searched PubMed, Embase, PsycINFO and SPORTDiscuss 96 
from database inception to October 18st, 2017. Keywords included a combination of terms 97 
related to physical activity, depression and longitudinal studies. Searches were adapted for 98 
each database and are displayed in the supplementary materials 1. Manual searches of the 99 
reference lists from recovered articles and other systematic reviews investigating the 100 
association between PA, sedentary behavior or fitness and depression were conducted (9, 10, 101 
13, 14).  102 
 103 
Inclusion and exclusion criteria 104 
 Articles were eligible if they met the following criteria: (1) evaluated participants, of all 105 
ages, free from depression/depressive symptoms at baseline. (2) PA was measured with a self-106 
report questionnaire (SRQ) such as the International Physical Activity Questionnaire (IPAQ) 107 
(15), single or multiple questions of exercise, sports or PA participation, or objective PA 108 
measures (e.g. accelerometers). PA was defined as any bodily movement produced by skeletal 109 
muscles and which requires energy expenditure (16). (3) Used a prospective study design with 110 
at least one-year period of follow-up duration. Prospective studies with less than one year follow 111 
up were not included, as this was not considered a sufficient time frame for risk and protective 112 
factors to exert a meaningful influence on depressive symptoms (17). (4) Evaluated incident 113 
depression as the outcome including increased depressive symptoms, through established cut-114 
offs of depression screening instruments (e.g. Beck Depression Inventory (BDI) I or II) (18) or 115 
based on tertiles, quartiles or quintiles of depression symptoms, major depressive disorder 116 
(MDD), diagnosed using structured or semi-structured diagnostic interviews (e.g. instruments 117 
using DSM (19) or ICD criteria (20)) or through a self-report of physician diagnosis of 118 
depression (5). Reported an adjusted or non-adjusted odds ratio (OR), hazard ratio (HR) or 119 
relative risk (RR) and 95% confidence intervals or the raw numbers of exposed and non-120 
exposed participants who developed depression at follow-up, in a way that allow calculations of 121 
ORs or RRs. In instances when data were not available we contacted corresponding authors at 122 
least three times over a 3-week period to request the data to enable inclusion in our meta-123 
analysis (see acknowledgments). To compare with most of the risk measures selected to the 124 
meta-analysis, the OR, RR or HR of studies using the lowest PA group as the reference group 125 
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had to be inverted. Likewise, the limits of the corresponding confidence intervals were also 126 
inverted, giving rise to the limits of the confidence intervals to the reciprocal of the OR, RR or 127 
HR (21) .  128 
 Excluded were: (1) studies without primary data (reviews, commentaries, editorials); (2) 129 
conference presentations without  information about the methods or the outcomes; (3) studies in 130 
languages other than English, Portuguese or Spanish; (4) studies that evaluated PA as a 131 
continuous measure.   132 
 Studies of the same epidemiological cohort were included only when they report the 133 
results in different metrics (OR or RR/HR). For example, if one study is reporting OR and other 134 
RR, each one was included in its analysis. This strategy allows the inclusion of the greatest 135 
number of studies without counting the same participants twice in each meta-analysis. When 136 
two or more studies report data of the same cohort, we selected the most recently published. 137 
Studies reporting subsamples of cohorts were excluded.  138 
 139 
Study selection 140 
In the first stage of study selection, two authors (FS, ES) independently screened titles and 141 
abstracts of all articles retrieved from the search. Afterwards, the full-text of potentially eligible 142 
references were reviewed in detail by the same investigators. Disagreements were resolved 143 
through discussion until consensus was achieved. A third reviewer (BS) was available for 144 
mediation.  145 
 146 
Outcomes 147 
The primary outcome was the adjusted odds ratio (AOR) for incident diagnosed depression or 148 
depressive symptoms and 95% confidence interval (CI).  149 
 150 
Data extraction 151 
Five authors (FS, ES, MH, JF and SR) independently extracted data including geographical 152 
location, name of cohort, number of participants included at baseline, age at baseline, PA 153 
assessment (instrument or questions used, what aspects of PA were considered by the 154 
measure to define PA levels (e.g. frequency, intensity, time, type, energetic amount expended, 155 
6 
 
steps, or other)), depression assessment (e.g. instrument and cut-off used, diagnostic criteria, 156 
medical records), follow-up period, odds ratio OR/RR/HR and 95% confidence interval and the 157 
number of covariates. The data utilized for the adjusted meta-analysis was the most adjusted 158 
model presented in each of the respective papers.  159 
 160 
Study quality 161 
The methodological quality of studies was assessed with the Newcastle-Ottawa Scale (NOS) by 162 
two authors (FS and SR). The NOS scale evaluates the risk of bias of prospective studies with 163 
three elements: (a) selection of participants, four items (representativeness of the exposed 164 
cohort, equal derivation between source of exposed and non-exposed participants, 165 
ascertainment of the exposure, demonstration that the outcome of interest was not present at 166 
the start of the study), (b) comparability, one item (comparability of cohorts on basis of the 167 
design of the analysis); Studies where the OR or RR were calculated on the basis of the raw 168 
number of participants provided from the original papers received zero points for comparability, 169 
and (c) outcomes, three items (adequate assessment of outcome, adequate time of follow-up 170 
and adequacy of follow-up). A study can be awarded a maximum of one point for each 171 
numbered item within the selection and outcome categories and a maximum of two stars can be 172 
given for comparability. The maximum score of the NOS is 9 (highest quality) and we assigned 173 
scores of 0–3, 4–6 and 7–9 for the low, moderate and high quality of studies, respectively 174 
(22). In case of disagreement, a consensus was reached through a discussion.  175 
 176 
Meta-analysis 177 
 A random-effects meta-analysis was conducted investigating the relationship between 178 
baseline PA and incident depression. Procedures included first pooling data across all studies 179 
comparing the incident depression in highest PA levels group (the group of greater frequency, 180 
intensity, volume, energetic expenditure or other, from each study, as defined by the authors)  181 
versus the lowest PA level group (reference group). Analysis for adjusted (AOR), crude OR, 182 
adjusted relative risks/hazard ratio (RR/HR) and crude RR/HR were conducted separately. 183 
Specifically, AOR, OR, ARR/AHR or HR/RR and 95% CI were calculated for incident 184 
depression. For the AOR and ARR/AHR, we pooled the estimates using the model with the 185 
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greatest number of covariates presented by the authors. Second, subgroup analyses were 186 
performed investigating the relationship between: 1) different geographical regions (different 187 
continents); 2) how PA levels were assessed (e.g. asking about intensity, frequency, volume 188 
(time spent in PA) or composite variables including two or more variables, and studies using 189 
metabolic equivalents [METS] as units were classified together with the METS category); 3) 190 
the mean age of the sample at baseline (e.g. children or adolescents (<18 years), adults (18-191 
65 years) or elderly (>65 years)); 4) the use of SRQ or objective measures to assess PA;  5) 192 
depression assessment method including screening instruments, MDD diagnosis, assessed 193 
by structured or semi-structured diagnostic instruments, or self-report (SR) of physician 194 
diagnosis of MDD; and, 6) the adjustment for potential confounders (age and sex, body mass 195 
index, smoking and baseline depressive symptoms, age and sex and more one of the three 196 
others, and age and sex and more two of the three others). Third, we evaluated potential 197 
moderators (% of males (only for crude OR and RR/HR), length of follow-up, year of 198 
publication, person-years, total number of participants at baseline, study quality according to 199 
the NOS scale overall score, and the score for the selection of participants, outcome and 200 
comparability (only for adjusted), and the number of covariates included in the model (only for 201 
AOR and ARR/AHR, to evaluate whether studies using more covariates are more likely to find 202 
significant or stronger effects) (23)  through meta-regression analysis. Lastly, we evaluated 203 
the publication bias using the Begg and Mazundar (24) and Egger tests (25) and corrected for 204 
this using the Duval and Tweedie trim and fill (26). To maximize statistical power, studies 205 
pooling participants with incident depressive disorders along with incident anxiety disorders 206 
were included in the main analysis. However, a sensitivity analysis excluding those papers 207 
were performed to evaluate whether they impacted the results obtained. Sensitivity analyses 208 
were also performed excluding studies of the same cohorts that have any potential sample 209 
overlapping. Heterogeneity was quantified using the Q and I2 statistic, with scores of <25%, 210 
25-50% and >50% indicating low, moderate and high heterogeneity, respectively (27). Finally, 211 
the fail-safe number of negative studies that would be required to nullify (i.e. make p>0.05) the 212 
effect size was calculated (28). All analyses were performed using Comprehensive Meta-213 
Analysis software (version 3). 214 
 215 
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Results 216 
Search results 217 
 The initial search yielded 13,474 results. After the removal of duplicates and exclusion 218 
at the title/abstract level, 10,099 abstracts were considered. At the full-text review stage, 430 219 
studies were considered, and 383 studies were subsequently excluded, and two were identified 220 
in the references of other included articles (see supplementary figure 1 for the flowchart and 221 
supplementary material 2 for a list of excluded articles). Therefore, 49 unique studies were 222 
included in the review.  223 
 224 
Studies and participants characteristics  225 
 Across the 49 unique prospective studies, 266,939 individuals were included, with 226 
nearly equal gender distribution  (47% males), followed up for an average of 7.4 years. The total 227 
person-years was 1,837,794. Of these, 39 cohorts from 36 unique studies provided data for 228 
AOR, 19 cohorts from 18 studies provided for OR, 18 cohorts from 15 studies provided for ARR 229 
and 15 cohorts from 13 studies for RR. Table 1 indicates the studies included in each analysis. 230 
Only one study used objective measures to evaluate PA. Fifteen studies evaluated MDD using 231 
structured or semi-structured diagnostic instruments or SR physician diagnosis of MDD only. 232 
The description in details of the included studies are summarized in table 1. The list of included 233 
studies is provided on supplementary material.  234 
 235 
Study quality 236 
 The mean (SD) study quality score of the studies was 6.34 (0.8) out of 9 on the NOS 237 
scale, representing moderate to high methodological quality. The detailed quality assessment is 238 
presented in supplementary table 1.  239 
 240 
Physical activity and incident depression 241 
Highest versus lowest PA  242 
 People with higher PA levels were at reduced odds of incident depression when 243 
compared to people with lower PA levels in adjusted (AOR=0.83, 95% CI=0.79 to 0.88, 244 
p<0.001, I2=0.00, Q-value=25.93, N=36) (figure 1) and crude odds ratio analyses (OR=0.59, 245 
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95% CI=0.51 to 0.68, p<0.001, I2=52.38, Q-value=37.80, N=19) and with decreased risks on 246 
adjusted (ARR=0.83, 95% CI=0.76 to 0.30, p<0.001, I2=0.00, Q-value=14.86, N=18) and crude 247 
relative risks analyses (RR=0.68, 95% CI=0.60 to 0.78, p<0.001, I2=33.40, Q-value=24.02, 248 
N=17). The plots for OR, ARR and RR can be seen at supplementary figures 2, 3 and 4, 249 
respectively, and the incidence rates can be seen at supplementary tables 3. Publication bias 250 
were evidenced for AOR (Egger's intercept=-0.65, p=0.002), ARR (Egger's intercept=-1.25, 251 
p<0.001; Begg and Mazundar Tau=-0.43, p=0.01). The Duval and Tweedie trim and fill 252 
technique adjusted the effects to: (1) AOR=0.85 (95% CI=0.81 to 0.89), (2) OR=0.63 (95% 253 
CI=0.54 to 0.74), (3) ARR=0.86 (95% CI=0.78 to 0.96); and (4) RR=0.80 (95% CI=0.69 to 0.94). 254 
The classic fail-safe n test revealed that 380, 519, 102 and 210 studies with negative results 255 
would be required to nullify the protective effect of PA on incident depression for AOR, OR, 256 
ARR and RR analyses respectively.  257 
  258 
Subgroup and sensitivity analysis  259 
 Significant protective associations of PA on incident depression were found across the 260 
four continents (Asia, Europe, North America and Oceania) with available data for AOR, and RR 261 
analysis. Protective effects were found for Asia, North America and Oceania for OR and for 262 
Europe, North America and Oceania in ARR analysis. Significant associations of high PA was 263 
found in all analysis for studies assessing PA levels considering different volumes and 264 
composed/METS. Higher frequency of PA provided protective effects in AOR and OR analysis, 265 
but not in ARR or RR. Higher intensity was significantly associated with lesser incident 266 
depression in all but AOR analysis. Protective effects were found for adults and older in all 267 
analyses and for children in AOR and RR. Significant associations were found for studies 268 
assessing depressive symptoms across the four analyses. PA was protective for MDD 269 
diagnosis in AOR, OR, and RR analyses. Significant reduction of 150 min of moderate/vigorous 270 
on the incident depression in AOR and ARR analyses. Lastly, subgroup analyses of studies that 271 
have adjusted for age and sex, body mass index, smoking, baseline depressive symptoms, or 272 
age and sex one more, or age and sex two more confounders are all significant in AOR. For 273 
ARR, adjusting for age and sex, body mass index, smoking, or age and sex and one more 274 
confounder. Details of the subgroup analyses can be seen in table 2. 275 
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 We performed sensitivity analyses removing the study that pooled participants with 276 
anxiety disorders together with depression both in the overall analysis (available upon request) 277 
and in MDD only (available upon request) (29), excluding the study that used objectively 278 
measured PA (available upon request) (30),. The results remained significant for all analyses.  279 
  280 
Meta-regressions  281 
Sample size at baseline, year of publication, the length of follow-up, individual study person-282 
years, the % of males, the number of covariates used in each study for adjusted analyses (the 283 
list of the covariates used can be seen in the supplementary table 2) and the study quality 284 
according to the NOS scale were investigated as potential moderators through meta-285 
regressions analysis. None of the investigated moderators significantly explained the variance 286 
of the effects of PA on depression onset in any of the analyses. Detailed results of meta-287 
regressions can be seen at table 3 (plots available upon author request).  288 
 289 
Discussion 290 
To the best of our knowledge, the current paper is the first to meta-analyze the 291 
relationship between PA levels and incident depression. Study findings indicate that across 52 292 
studies, higher PA is associated with a decreased odds of developing future depression. The 293 
results remained robust after adjustment for potential publication bias. Moreover, our results 294 
indicate that higher levels of PA offer a protective effect on future development of depression for 295 
people of all ages (youth, working age adults, elderly) and this finding is robust across 296 
geographical regions around the world.  297 
Previous narrative systematic reviews have suggested that PA can be protective 298 
against the development of depression (9, 10). Our study advances the field by conducting the 299 
first pooled meta-analysis investigating this relationship, which enables a clearer understanding 300 
of a true association between an exposure and outcome, rather than when studies are 301 
considered separately as in previous reviews (34). Recently, a meta-analysis including 11 302 
prospective studies found that sedentary behavior (SB) is associated with an increased incident 303 
depression at follow-up (RR=1.14, 95%CI=1.06 to 1.21) (14). While sedentary behaviour and 304 
PA are related constructs - with the former existing at the low end of the PA spectrum – it is of 305 
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clinical relevance to quantify the pooled relationships of PA with subsequent depression onset 306 
independently of sedentary behaviour.  307 
Mammen and Faulkner reported previously that gender might modify the effect of PA on 308 
incident depression (9). This assumption was not supported in our meta-regression analysis,  309 
suggesting that the potential protective association of PA is similar for men and women. Also, 310 
we demonstrated that PA has protective effects on depression across different geographical 311 
regions, and for people of all ages. Importantly, PA was assessed by different parameters such 312 
as frequency, intensity, volume and type that can be captured to discriminate different PA 313 
levels. Our subgroup analyses demonstrated that the protective effects of PA are found in 314 
studies in which the different aspects of PA (intensity, frequency, volume) were measured 315 
individually or when two or more (METS/composed) were considered.  316 
Our meta-analysis suggests that PA is associated with a decrease in the risk of 317 
developing depression, which raises an inevitable question; how might PA offer protection 318 
against depression onset? It is likely that no single mechanism can explain this relationship. A  319 
range of biochemical and psychosocial factors are likely responsible including biological 320 
mechanisms showing that exercise increases neurogenesis and reduces inflammatory and 321 
oxidant markers (35) and activate the endocannabinoid system (36). People with depression 322 
have decreased hippocampal volumes and levels of markers of neurogenesis, and increased 323 
levels of inflammatory (e.g: interleukin-6) (37) and oxidant markers (37). Physical activity, in 324 
turn, may regulate these abnormalities increasing hippocampal volume (38) and neurogenesis 325 
levels (39), as well as, adjusting the imbalance between anti- and proinflammatory (40) and 326 
oxidant markers (41, 42). Also, physical activity may directly increase psychological factors such 327 
as increased self-esteem or perceptions of physical competence. Finally, an improved level of 328 
fitness leads to both subjective and objective improvements in physical health status (43). 329 
Productive areas of future research include physical activity interventions to prevent symptoms 330 
of depression and the underlying biological and psychological mechanisms. 331 
 332 
Limitations and future research  333 
 Some limitations were present in our meta-analysis. First, the use of SRQs to measure 334 
the exposure factor and the outcome. While common in the PA literature, SRQs are associated 335 
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with recall biases. However, only one of the included studies used an objective measure 336 
(pedometer) (30) to evaluate PA, thus precluding exploration as to results were different with 337 
SRQs compared to objective measures. Also, subgroup analyses showed that PA decreased 338 
the risk of developing depression, regardless of whether this was based on self-report 339 
measures or MDD diagnosis from structured clinical diagnostic interviews (e.g.: MINI, CIDI, 340 
SCID). Second, we found some evidence of publication bias, in AOR and ARR. Nonetheless, 341 
adjusting for publication bias, after trimming 10 studies for AOR and 8 studies for ARR, resulted 342 
in smaller but still significant associations (AOR=0.85; 95% CI=0.81 to 0.89; ARR=0.86; 95% 343 
CI=0.78 to 0.96). Therefore, the primary results of our analyses are not altered by considering 344 
the potential number of unpublished studies. Third, it should be noted that we only included 345 
studies in which there were no depressed participants at baseline, which minimizes the risk of 346 
selection bias. Despite this, the risk of selection bias was not entirely excluded since depression 347 
is a recurrent disorder and previous depressive episodes were not well-documented in the 348 
studies we investigated. Fourth, we were able to perform subgroup analyses including studies 349 
that evaluated the protective effect of 150 minutes of moderate to vigorous PA per week. 350 
However, these analyses included a small number of studies. Also, in all the other studies, the 351 
definition of low or high PA, as well as what aspects of PA (intensity, frequency, volume or two 352 
or more) that were captured by each instrument varied largely. These limitations prevent the 353 
present review from establishing the "minimum" or the "optimal" dose of PA necessary to 354 
decrease the odds of incident depression. However, we can conclude that people with higher 355 
levels of PA have a lower risk of developing depression than those with lower levels of PA. Fifth, 356 
seven of our subgroup analyses were non-significant. It should be considered that those 357 
analyses included a small number of studies and potentially are underpowered. Lastly, the 358 
included studies have assessed PA participation using questionnaires over the preceding days 359 
or weeks. Thus, it is not possible to evaluate whether being engaged in higher levels of PA for 360 
longer periods confers greater protection in comparison to shorter periods.  361 
 Despite the robustness of our findings across age ranges, geographical regions, and 362 
the different aspects of PA (frequency, intensity, time, type), some caution is required given that 363 
there may be a number of covariates that were not assessed. For example, some evidence 364 
suggests that the protective effects of PA seems to be greater in the non-carriers of the E type 4 365 
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allele of the apolipoprotein E (APOE) gene (45), and that carriers of the Met allele of the brain-366 
derived neurotrophic factor (BDNF) gene are more likely to experience greater benefits for 367 
somatic symptoms from exercise interventions (46). Also, the effects of PA in people with 368 
increased risk for depression, such as people with a familial history of depression, was not yet 369 
examined.  370 
 Differences in the assessment of depressive symptoms at baseline across studies is 371 
also a limitation. It is possible that the inclusion of participants who exhibited subthreshold 372 
symptoms depressive symptoms at baseline could have influenced the likelihood to develop 373 
depression at follow-up not only due to a lower engagement in physical activity but also to an 374 
inherently higher risk to develop full-blown depression. Nonetheless, significant associations 375 
between high PA and lower development of depression has been reported by included studies 376 
which controlled for baseline depressive symptom severity in subgroup analysis for AOR thus 377 
showing the protective effect of PA also in people with sub-threshold depressive symptoms. 378 
Only one study have adjusted for depressive symptoms at baseline for ARR and found no 379 
significant associations, but it should be considered that it this analysis is based on a single 380 
study. Also, people with lower PA levels may have other risk factors for depression, as such as 381 
obesity, poor diet, use of tobacco and other clinical comorbidities. Therefore, due to the 382 
observational nature of the included studies, it is possible that these other correlated factors 383 
contributed to increased risk of incident depression among those with low PA. 384 
 Further studies are warranted to  evaluate the minimum PA levels required, as well as, 385 
the effects of different PA types and ‘dosages’ on subsequent risk for depression. Also, further 386 
studies accounting for genetic variations and assessing people with increased risk for 387 
depression are required. Lastly, considering the burden of disease and the global impact of 388 
mental illness, further studies should evaluate the cost-effectiveness of PA in the prevention of 389 
depression.    390 
 391 
Conclusion 392 
 Higher levels of physical activity are consistently associated with a lower odds of 393 
developing future depression. The protective effects of PA were observed regardless of gender 394 
and age, and was significant across all geographical regions. Our data further emphasize the 395 
14 
 
importance for policies targeting increased PA levels. Future randomised controlled trials are 396 
required to address whether or not physical activity can prevent the development of depression 397 
in those at high risk.   398 
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